Institutions / Perceptive Advisors LLC / Holdings

Perceptive Advisors LLC

All holdings · as of Mar 31, 2026

Company	Class	Value ↓	Shares	% of portfolio
Praxis Precision Medicines, Inc.	—	$655.97M	2,035,986	13.0%
Celcuity Inc.CELC	Common Stock	$356.94M	3,127,200	7.1%
ASCENDIS PHARMA A/S	—	$350.28M	1,531,421	6.9%
Roivant Sciences Ltd.	—	$229.51M	8,285,461	4.5%
CENTESSA PHARMACEUTICALS PLC	—	$208.88M	5,258,903	4.1%
RHYTHM PHARMACEUTICALS, INC.	—	$206.45M	2,373,795	4.1%
SPYRE THERAPEUTICS, INC.	—	$190.83M	3,783,225	3.8%
Nuvalent, Inc.	—	$161.92M	1,580,505	3.2%
Edgewise Therapeutics, Inc.	—	$139.36M	4,423,974	2.8%
PROTAGONIST THERAPEUTICS INC	—	$129.73M	1,230,879	2.6%
Apogee Therapeutics, Inc.	—	$129.65M	1,540,384	2.6%
Travere Therapeutics, Inc.	—	$123.08M	4,142,551	2.4%
Amylyx Pharmaceuticals, Inc.	—	$115.16M	8,284,882	2.3%
IMMATICS N.V	—	$102.17M	10,383,456	2.0%
Relay Therapeutics, Inc.	—	$97.02M	9,751,141	1.9%
Inhibrx Biosciences, Inc.	—	$96.99M	1,442,707	1.9%
MEIRAGTX HLDGS PLC	—	$89.31M	10,326,103	1.8%
ZYMEWORKS INC.	—	$87.89M	3,510,078	1.7%
Solid Biosciences Inc.SLDB	Common Stock	$85.73M	11,906,646	1.7%
Dyne Therapeutics, Inc.	—	$84.65M	4,668,839	1.7%
BIOCRYST PHARMACEUTICALS INC	—	$70.77M	7,434,033	1.4%
Oruka Therapeutics, Inc.	—	$68.45M	1,395,501	1.4%
ARTIVION, INC.	—	$59.96M	1,637,290	1.2%
Nurix Therapeutics, Inc.	—	$57.52M	3,710,877	1.1%
Nautilus Biotechnology, Inc.NAUT	Common Stock	$48.87M	12,594,211	1.0%
CytomX Therapeutics, Inc.	—	$47.46M	10,098,824	0.9%
Alto Neuroscience, Inc.ANRO	Common Stock	$45.18M	2,009,893	0.9%
enGene Therapeutics Inc.	—	$39.69M	5,827,506	0.8%
Immunovant, Inc.IMVT	Common Stock	$39.68M	1,597,383	0.8%
Intuitive Surgical Inc	—	$39.38M	85,419	0.8%
IONIS PHARMACEUTICALS INC	—	$37.85M	504,000	0.7%
Day One Biopharmaceuticals, Inc.	—	$37.64M	1,755,799	0.7%
ABIVAX SA	—	$36.62M	328,884	0.7%
Corvus Pharmaceuticals, Inc.	—	$33.54M	2,292,441	0.7%
REPLIGEN CORP	—	$33.05M	280,541	0.7%
Jazz Pharmaceuticals PLC	—	$32.14M	170,000	0.6%
DAMORA THERAPEUTICS INC	—	$31.68M	1,223,000	0.6%
X4 Pharmaceuticals, Inc	—	$27.83M	6,737,648	0.5%
Guardant Health, Inc.	—	$27.71M	300,000	0.5%
BRIGHT MINDS BIOSCIENCES INC.	—	$27.55M	377,544	0.5%
Invivyd, Inc.	—	$27.12M	20,859,303	0.5%
Sionna Therapeutics, Inc.	—	$26.40M	658,439	0.5%
Axsome Therapeutics, Inc.	—	$25.34M	149,950	0.5%
Revolution Medicines, Inc.	—	$25.15M	258,600	0.5%
SAB Biotherapeutics, Inc.	—	$24.63M	6,431,743	0.5%
BELITE BIO, INCBLTE	ADR	$24.23M	151,979	0.5%
Tenax Therapeutics, Inc.	—	$23.15M	1,447,782	0.5%
Axogen, Inc.	—	$23.10M	697,312	0.5%
Viridian Therapeutics, Inc.	—	$22.90M	1,170,829	0.5%
Orchestra BioMed Holdings, Inc.OBIO	Common Stock	$21.41M	5,037,906	0.4%